IRD Company Profile and Key Details

NASDAQ : IRD

Opus Genetics

$3.35

0.27+8.77%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Opus Genetics, Inc. (IRD) stock surged +1.79%, trading at $3.41 on NASDAQ, up from the previous close of $3.35. The stock opened at $3.29, fluctuating between $3.23 and $3.50 in the recent session.

Stock Snapshot

3.35

Prev. Close

281.55M

Market Cap

3.23

Day Low

-2.89

P/E Ratio

-1.18

EPS (TTM)

N/A

Cash Flow per Share

3.29

Open

82.57M

Number of Shares

3.495

Day High

46.27%

Free Float in %

N/A

Book Value

668.28K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 27, 2026	3.08	3.38	3.08	3.35	538.57K
Jul 24, 2026	2.91	3.09	2.82	3.08	1.09M
Jul 23, 2026	3.00	3.06	2.90	2.92	1.45M
Jul 22, 2026	3.03	3.10	3.00	3.05	555.51K
Jul 21, 2026	3.05	3.12	2.96	3.06	970.56K
Jul 20, 2026	3.22	3.37	3.00	3.05	1.21M
Jul 17, 2026	3.22	3.38	3.18	3.27	506.28K
Jul 16, 2026	3.48	3.48	3.21	3.28	1.11M
Jul 15, 2026	3.55	3.58	3.41	3.48	667.22K
Jul 14, 2026	3.82	3.85	3.56	3.56	970.56K
Jul 13, 2026	3.90	3.91	3.76	3.81	894.7K
Jul 10, 2026	4.01	4.02	3.84	3.92	591.94K
Jul 09, 2026	4.12	4.23	3.94	4.02	868.93K
Jul 08, 2026	4.02	4.24	3.98	4.10	771.43K
Jul 07, 2026	4.11	4.17	3.80	4.05	1.03M
Jul 06, 2026	4.24	4.39	4.07	4.07	873.13K
Jul 02, 2026	4.20	4.38	4.11	4.23	847.55K
Jul 01, 2026	4.06	4.24	3.93	4.18	805.41K
Jun 30, 2026	4.05	4.17	4.00	4.11	681.88K
Jun 29, 2026	4.03	4.18	3.97	4.06	821.19K

Contact Details

Durham, NC 48335

United States

https://opusgtx.com 248 957 9024

About Company

Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.

Stock Peers

ARGX

-29.4-3.20%

argenx SE$888.82 REGN

11.16+1.70%

Regeneron Pharmaceuticals, Inc.$667.17 MDGL

6.74+1.24%

Madrigal Pharmaceuticals, Inc.$551.25 UTHR

-0.53-0.10%

United Therapeutics Corporation$527.94 VRTX

1.64+0.34%

Vertex Pharmaceuticals Incorporated$479.00 KRYS

16.63+4.96%

Krystal Biotech, Inc.$351.82 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

BeOne Medicines AG$325.90 PRAX

-9.5-2.92%

Praxis Precision Medicines, Inc.$315.80 LGND

-3.03-1.01%

Ligand Pharmaceuticals Incorporated$297.50

Frequently Asked Questions

What is the current Opus Genetics, Inc. (IRD) stock price?

Opus Genetics, Inc. (NASDAQ: IRD) stock price is $3.41 in the last trading session. During the trading session, IRD stock reached the peak price of $3.50 while $3.23 was the lowest point it dropped to. The percentage change in IRD stock occurred in the recent session was 1.79% while the dollar amount for the price change in IRD stock was $0.06.

IRD's industry and sector of operation?

The NASDAQ listed IRD is part of Biotechnology industry that operates in the broader Healthcare sector. Opus Genetics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IRD?

No Data

How IRD did perform over past 52-week?

IRD's closing price is 222.12% higher than its 52-week low of $1.04 where as its distance from 52-week high of $5.81 is -42.34%.

How many employees does IRD have?

Number of IRD employees currently stands at 28.

Link for IRD official website?

Official Website of IRD is: https://opusgtx.com

How do I contact IRD?

IRD could be contacted at phone 248 957 9024 and can also be accessed through its website. IRD operates from 8 Davis Drive, Durham, NC 48335, United States.

How many shares of IRD are traded daily?

IRD stock volume for the day was 668.28K shares. The average number of IRD shares traded daily for last 3 months was 1.02M.

What is the market cap of IRD currently?

The market value of IRD currently stands at $281.55M with its latest stock price at $3.41 and 82.57M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	28
Beta	0.56
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

IRD Company Profile and Key Details

Opus Genetics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics